![]() |
市場調査レポート
商品コード
1722534
骨成長刺激装置市場レポート:製品、用途、エンドユーザー、地域別、2025年~2033年Bone Growth Stimulator Market Report by Product, Application, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
骨成長刺激装置市場レポート:製品、用途、エンドユーザー、地域別、2025年~2033年 |
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
|
世界の骨成長刺激装置の市場規模は2024年に22億米ドルに達しました。今後、IMARC Groupは、2033年には34億米ドルに達し、2025年から2033年にかけて4.8%の成長率(CAGR)を示すと予測しています。同市場は、事故やスポーツ外傷、加齢に起因する骨折の増加、ユーザーフレンドリーな機器の市場開拓、非侵襲的な治療ソリューションへの嗜好の高まりなどを背景に、安定した成長を遂げています。
主な市場促進要因:骨成長刺激装置の市場展望によると、主な促進要因には、スポーツ関連の傷害の増加、骨癒合の促進や回復時間の短縮の利点に関する認識、電磁波や超音波ベースの刺激装置の市場開拓などの急速な技術発展が含まれます。
主要市場動向:骨成長刺激装置の市場統計に基づくと、注目すべき動向としては、非侵襲的治療へのシフトの進行、ポータブルでユーザーフレンドリーな機器への需要の高まり、再生医療における継続的な進歩などが挙げられます。
地理的動向:北米は確立されたヘルスケアインフラの存在により市場をリードしています。しかし、アジア太平洋地域は、患者の間で治療ソリューションの強化への注目が高まっていることから、急成長市場として浮上しています。
競合情勢:骨成長刺激装置の業界の主要市場プレイヤーには、Arthrex Inc.、DJO Global Inc.、Elizur Corporation、IGEA S.p.A.、Isto Biologics、Ito Co.Ltd.、Medical Device Business Services Inc.(ジョンソン・エンド・ジョンソン)、Medtronic Plc、Orthofix Medical Inc.、Ossatec Benelux B.V.、Stryker Corporation、Terumo Bct Inc.(テルモ株式会社)、Zimmer Biometなどです。
課題と機会:骨成長刺激装置の市場概要によると、市場は継続的な調査検証の必要性などの課題に直面しています。また、より高度で費用対効果の高いデバイスの開発という機会にも遭遇しています。
骨折の増加
骨折の増加による骨成長刺激装置の採用増加は、骨成長刺激装置の用途にプラスの影響を与えています。それに伴い、骨折は事故やスポーツによる怪我、加齢によるものなど様々な理由で発生します。世界保健機関(WHO)によると、2,000万人から5,000万人が交通事故で致命的でない怪我を負い、骨折や怪我につながり、効果的な治療法が必要とされています。さらに、骨密度の低下により骨折しやすくなる老年人口の間で骨成長刺激剤の採用が増加していることが、市場の成長を促進しています。これとは別に、骨成長刺激装置は、より迅速で効果的な骨治癒のための実行可能なソリューションを提供し、ヘルスケア専門家や患者の間で好ましい選択肢となっています。さらに、患者の間で治療ソリューションの強化への注目が高まっていることも、骨成長刺激装置の市場の機会を後押ししています。さらに、従来の骨折治療と比較して、より早い回復と痛みの軽減を支援することから、骨成長刺激装置を好む人が増えています。
技術の進歩
技術の進歩は、より高度で、効率的で、ユーザーフレンドリーなデバイスの開発を支援し、市場の成長に寄与しています。さらに、骨再生を刺激するために、電磁場、超音波、パルス電磁場(PEMF)などの先端技術を組み込んだ骨成長刺激装置の使用が増加していることも、市場成長に好影響を与えています。これとは別に、機器の設計や機能性の向上は治療成果を高めるだけでなく、患者のコンプライアンスも向上させる。さらに、患者が日常生活に取り入れることができるため、高度な制御機能を備えた小型で携帯可能な機器の採用が増加していることも、骨成長シミュレーター市場のシェアを支えています。これに伴い、ヘルスケアプロバイダーは患者のために効果的でエビデンスに基づいたソリューションを求めています。さらに、大衆の間でより効果的で魅力的な治療オプションに対する需要が高まっていることも、市場成長を後押ししています。さらに、ワイヤレス接続機能を備えた先進的な骨成長刺激装置の導入により、ヘルスケアプロバイダーは患者のコンプライアンスや治療の進捗状況を遠隔でモニターできるようになりました。例えば、Orthofix Medical Inc.は、骨成長刺激装置を進化させるモバイルアプリバージョン2.1 STIMonTrackの米国FDA承認を発表しました。
非侵襲的治療ソリューションへの嗜好の高まり
非侵襲的で痛みを伴わない治療オプションに対する患者の需要の高まりは、骨成長刺激装置の市場の収益を押し上げる要因となっています。これに伴い、患者は手術や侵襲的な処置に代わるものを求めるようになっています。さらに、骨成長刺激剤は骨治癒のための非外科的選択肢を提供します。さらに、非侵襲的治療は患者の不快感を軽減するだけでなく、合併症や感染のリスクも最小限に抑えることができます。このため、骨成長刺激装置は、手術をためらっている患者や侵襲的な処置に禁忌のある患者など、幅広い患者にとって特に魅力的です。これとは別に、非侵襲的治療はしばしば回復時間の短縮につながり、患者はより早く日常生活を再開することができます。さらに、患者中心のアプローチへの注目が高まっていることも、市場の成長を後押ししています。さらに、非侵襲的治療は外科的治療と比較して費用対効果が高く、必要な病院資源が少なく、入院期間が短く、医療費全体を削減できるため、骨成長刺激装置の市場価格にプラスの影響を与えています。
The global bone growth stimulator market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The market is experiencing stable growth driven by the growing incidences of bone fractures due to accidents, sports injuries, and age-related factors, rising development of user-friendly devices, and increasing preferences for non-invasive treatment solutions.
Major Market Drivers: According to the bone growth stimulator market outlook, key drivers include the rising sports-related injuries, awareness about the benefits of accelerated bone healing and reduced recovery time, and rapid technological advancements, such as the development of electromagnetic and ultrasound-based stimulators.
Key Market Trends: Based on the bone growth stimulator market statistics, notable trends include the ongoing shift towards non-invasive treatments, growing demand for portable, user-friendly devices, and ongoing advancements in regenerative medicine.
Geographical Trends: North America leads the market, driven by the presence of well-established healthcare infrastructure. However, Asia Pacific is emerging as a fast-growing market due to the increasing focus on enhanced treatment solutions among patients.
Competitive Landscape: Some of the major market players in the bone growth stimulator industry include Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation), and Zimmer Biomet, among many others.
Challenges and Opportunities: As per the bone growth stimulator market overview, the market faces challenges, such as the need for continuous research validation. It also encounters opportunities in developing more advanced and cost-effective devices.
Rising incidences of bone fractures
The growing adoption of bone growth stimulators due to rising incidences of bone fractures among individuals is positively impacting the uses of bone growth stimulator. In line with this, bone fractures can occur due to various reasons, such as accidents, sports injuries, and age-related factors. According to the World Health Organization (WHO), between 20 and 50 million people suffer non-fatal injuries in road accidents, leading to fracturs and injuries that require effective treatment options. Moreover, the rising employment of bone growth stimulators among the geriatric population, as they are more prone to fracture issues due to reduced bone density, is propelling the growth of the market. Apart from this, bone growth stimulators offer a viable solution for quicker and more effective bone healing, making them a preferred choice among healthcare professionals and patients. In addition, the increasing focus on enhanced treatment solutions among patients is impelling the bone growth stimulator market opportunities. Furthermore, people are increasingly preferring bone growth stimulators, as they assist in faster recovery and reduced pain as compared to traditional fracture treatments.
Technological advancements
Technological advancements assist in the development of more advanced, efficient, and user-friendly devices, which is contributing to the market growth. In addition, the increasing use of bone growth stimulators that incorporate advanced technologies, such as electromagnetic fields, ultrasound, and pulsed electromagnetic fields (PEMF), to stimulate bone regeneration, is favoring the market growth. Apart from this, improved device design and functionality not only enhance treatment outcomes but also improve patient compliance. Furthermore, the rising adoption of smaller and portable devices with advanced control, as they allow patients to incorporate them into their daily routines, is supporting the bone growth simulator market share. In line with this, healthcare providers are seeking effective and evidence-based solutions for their patients. Additionally, the increasing demand for more effective and appealing treatment options among the masses is propelling the market growth. Moreover, the introduction of advanced bone growth stimulators that are equipped with wireless connectivity, enables healthcare providers to monitor patient compliance and treatment progress remotely. For instance, Orthofix Medical Inc announced U.S. FDA approval of mobile app version 2.1 STIMonTrack to advance bone growth stimulators.
Increasing preferences for non-invasive treatment solutions
The increasing demand for non-invasive and painless treatment options among patients is positively impelling the bone growth stimulator market revenue. In line with this, patients are increasingly seeking alternatives to surgery and invasive procedures. Additionally, bone growth stimulators provide a non-surgical option for bone healing. Furthermore, non-invasive treatments not only reduce patient discomfort but also minimize the risk of complications and infection. This makes bone growth stimulators particularly appealing to a broad spectrum of patients, including those who are hesitant about surgery or have contraindications for invasive procedures. Apart from this, non-invasive treatments often lead to shorter recovery times, allowing patients to resume their daily activities more quickly. Moreover, the rising focus on patient-centric approaches is bolstering the market growth. In addition, non-invasive treatments are more cost-effective as compared to surgical procedures, as they require fewer hospital resources, shorter hospital stays, and reduce overall healthcare expenses, which is positively influencing the bone growth stimulator market price.
Bone growth stimulation devices accounts for the majority of the market share
According to the bone growth stimulator market segment based on the product, bone growth stimulation devices hold the largest share. They are non-invasive medical instruments designed to promote the natural healing of bones. They work by delivering specific types of energy, such as electromagnetic fields, ultrasound waves, or electrical currents, to the site of the bone injury or fracture. In line with this, these devices are usually available in various forms, such as wearable braces, portable units, or implantable options. The choice of device depends on the nature and location of the fracture. They accelerate the production of bone-forming cells, such as osteoblasts, aiding in the repair and regeneration of damaged bone tissues.
Spinal fusion surgeries hold the largest share of the industry
According to the bone growth stimulator market trends, spinal fusion surgeries represented the largest market share. They involve joining two or more vertebrae in the spine to treat conditions like spinal instability, degenerative disc disease, or spinal fractures. In spinal fusion, bone growth stimulators play a critical role in promoting the fusion process. They stimulate bone healing at the surgical site, helping the vertebrae to fuse together more effectively and securely. The growing number of spinal-related conditions, along with the rising need for improved surgical outcomes, is positively impacting the future of bone growth stimulators.
Hospitals and clinics represent the leading market segment
As per the bone growth stimulator market segments, hospitals and clinics often use bone growth stimulators in various applications, including orthopedic surgeries, fracture management, and post-operative care. In hospitals, these stimulators are employed by orthopedic surgeons and in physical therapy departments to aid in the healing of bone fractures, spinal fusion procedures, and other orthopedic conditions. The institutional setting of hospitals and clinics ensures that patients receive expert care and guidance during the use of bone growth stimulators.
North America leads the market, accounting for the largest bone growth stimulator market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for bone growth stimulator.
According to the bone growth stimulator market trends, North America accounted for the largest market share due to the presence of well-established healthcare infrastructure, such as hospitals and clinics. In line with this, key players are developing advanced bone growth stimulator devices, which are bolstering the growth of the market in the region. Moreover, stringent regulatory frameworks for medical devices to ensure enhanced safety and efficacy are propelling the market growth.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the bone growth stimulator industry include Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation), Zimmer Biomet, etc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Recent reports analyzing how big is the bone growth stimulator market highlighted that key players in the industry are focusing on developing advanced bone growth stimulator devices by incorporating advanced technologies, improving device design, and enhancing treatment efficacy. In line with this, companies are conducting clinical trials to demonstrate the safety and effectiveness of their products. Moreover, they are expanding their product portfolios to offer a range of bone growth stimulator options, such as devices tailored as per specific applications, including spinal fusion or fracture healing, positively impacting the bone growth stimulator market price. Apart from this, manufacturers are collaborating with healthcare institutions, research organizations, and academic institutions to facilitate research, development, and the validation of bone growth stimulator technologies. Furthermore, they are working closely with regulatory authorities to obtain approvals and certifications for their devices.
February 13, 2020: Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, announced that the U.S. Food and Drug Administration (FDA) approved the use of STIM onTrack mobile app version 2.1 with the bone growth stimulators of the company. The mobile device app is an accessory designed to help patients adhere to their prescriptions and improve their clinical outcomes.
January 8, 2020: Medtronic Plc acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM(TM)) spinal cord stimulation. The therapy, which is delivered via the Medtronic Intellis platform, is a new and unique programming option to treat patients with chronic pain.
May 17, 2021: IGEA S.p.A. signed an exclusive license agreement with Orthofix Medical Inc. to commercialize overseas the range of innovative products dedicated to stimulation. In addition, the bone growth stimulation and joint preservation devices will be commercialized in the United States and Canada.